Skip to main content
. 2015 Oct 19;6(41):43472–43482. doi: 10.18632/oncotarget.6179

Figure 3. Immune microenvironment analysis of MMR-D CRC alone or with Bethesda criteria.

Figure 3

A. Frequency of patients with CD80+ tumor cells. B. Infiltration of TIMC in CRC. C. Frequency of patients with CD8+ lymphocytes in the tumor microenvironment. D. Ratio of Tbet+ cells among CD4 lymphocytes in the tumor microenvironment. TIMC tumor infiltrating mononuclear cells; CRC colorectal cancer; MMR-D mismatch repair deficient; BC Bethesda criteria.